title: Acute post-infectious glomerulonephritis in adults: a single center report.
abstract: Acute post-infectious glomerulonephritis (APIGN) is uncommonly seen in adults; its incidence is progressively declining, particularly in developed countries. The aim of this study was to evaluate the epidemiological, clinical and biologic features of APIGN in a Tunisian center. A retrospective descriptive analytic study was carried out on 50 patients aged more than 15 years who were admitted to the Monastir Hospital between 1991 and 2007, with a diagnosis of APIGN. There were more males than females (66% vs. 34%), and the mean age of the patients was 36.8 ± 10 years. Only 10% had an immunocompromised background, including diabetes. The most common site of infection was upper respiratory tract, followed by skin and pneumonia. The most common causative agent was Streptococcus (66%), followed by Staphylococcus (12%). 73.8% of the patients had low C3 complement levels. The mean peak serum creatinine was 190 μmol, and 4% of patients required acute dialysis. The patients were followed-up for a mean period of 18 months (range, 0.16-97 months). During follow-up, of the 46 patients reviewed in the consultation, the majority showed complete remission, 12 patients had persisting abnormalities such as hypertension in 17%, chronic renal failure in 8% and proteinuria in 6.5%, and one patient had concomitant hypertension and chronic renal failure. Our study suggests that APIGN is still endemic in some parts of the world such as Tunisia, and our data showed a favorable prognosis in adults.
authors.affiliation: Department of Nephrology, Fattouma Bourguiba Hospital; University Faculty of Medicine, Monastir, Turkey.
authors.forename: Mouna
authors.initials: M
authors.lastname: Hamouda
authors.forename: I
authors.initials: I
authors.lastname: Mrabet
authors.forename: N Ben
authors.initials: NB
authors.lastname: Dhia
authors.forename: S
authors.initials: S
authors.lastname: Aloui
authors.forename: A
authors.initials: A
authors.lastname: Letaif
authors.forename: M A
authors.initials: MA
authors.lastname: Frih
authors.forename: H
authors.initials: H
authors.lastname: Skhiri
authors.forename: M
authors.initials: M
authors.lastname: Elmay
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D003141:Communicable Diseases / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology / Q000628:therapy; D015897:Comorbidity; D003176:Complement C3 / Q000032:analysis; D003404:Creatinine / Q000097:blood; D005260:Female; D005921:Glomerulonephritis / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology / Q000628:therapy; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D006435:Renal Dialysis; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D014416:Tunisia / Q000453:epidemiology; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D015415:Biomarkers; D003176:Complement C3; D003404:Creatinine